STOCK TITAN

BIO-key International, Inc. - BKYI STOCK NEWS

Welcome to our dedicated page for BIO-key International news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on BIO-key International stock.

BIO-key International, Inc. (OTCQB: BKYI) is a leading provider of biometric software and hardware authentication solutions for enterprises and consumers alike. Established in 1993, BIO-key has become a trusted name, servicing diverse sectors including Fortune 500 companies, government agencies, healthcare organizations, call centers, schools, retailers, and OEM partners.

BIO-key's product portfolio includes advanced fingerprint biometric identification and identity verification technologies, with popular offerings such as SideSwipe, SidePass, EcoID, and WEB-key. The company's innovative solutions ensure secure and seamless access management, making them a preferred choice for high-security requirements.

In 2016, BIO-key introduced a series of compact fingerprint readers designed for compatibility with Windows Hello. These readers are not only affordable but also easy to install and use, available through major retailers like Amazon, Microsoft, and Dell.com. The company further expanded its consumer reach by launching a series of biometric padlocks at the Consumer Electronics Show in 2017. Their product, TouchLock, received significant acclaim, being featured on over 30 morning television shows.

BIO-key continues to innovate with its 'Biometric of Things' (BoT) initiative, aiming to create a range of biometrically enabled, consumer-friendly products. The company’s focus on the power of a touch drives their mission to enhance security and user experience across various applications.

Financially, BIO-key generates revenue through services, license fees, and other streams. The company remains committed to partnerships and collaborations that expand their market presence and technological capabilities.

One notable partnership is with Humanity International Investments, under the chairmanship of His Highness, Sheikh Marwan bin Mohamed bin Rashid Al Maktoum. This strategic collaboration has led to the launch of the Humanity Protocol, a blockchain-based economic empowerment initiative. The project leverages BIO-key’s biometric palm scan technology to authenticate identities, enabling individuals, particularly in Africa, to claim their digital footprint through Non-Fungible Tokens (NFTs). With over 15,000 palm scans and plans to verify more users, the initiative marks a significant step forward in integrating biometric technology with blockchain for identity verification.

Overall, BIO-key International, Inc. is at the forefront of revolutionizing digital identity and access management, ensuring secure, user-friendly authentication solutions for millions worldwide.

Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) announced its selection by the U.S. General Services Agency (GSA) to implement its PortalGuard IAM solution, enhancing secure two-factor authentication for a public communication application. The GSA's Office of Information Technology required two-factor authentication for its Listserv web interface, and BIO-key's solution offers a streamlined enrollment process with fifteen authentication methods, including biometrics and SMS PINs. CEO Mike DePasquale emphasized the importance of stringent security compliance for government agencies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30.95%
Tags
none
-
Rhea-AI Summary

On October 8, 2020, BIO-key International (BKYI) announced its selection by the U.S. Government Services Agency (GSA) to provide its PortalGuard identity and access management solution. This initiative aims to implement secure two-factor authentication for a public-facing communication application, enhancing security for Listserv users. PortalGuard offers various authentication methods, including biometrics and SMS. CEO Mike DePasquale emphasized the importance of stringent security compliance for government agencies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30.95%
Tags
none
-
Rhea-AI Summary

BIO-key International (BKYI) has been selected by Partners in Health (PIH) to implement its PortalGuard Identity and Access Management (IAM) solution. This initiative aims to resolve PIH's difficulties with password resets and enhance secure access to critical applications for a global, often remote user base. The project initially focused on self-service password resets but expanded to include a single sign-on solution for various enterprise applications. Mark Cochran emphasized the importance of effective IAM in managing healthcare access swiftly and safely.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.38%
Tags
none
Rhea-AI Summary

BIO-key International, Inc. (NASDAQ: BKYI) announced updates on its African business, focusing on Nigeria despite COVID-19 impacts. The company's Nigeria subsidiary is pursuing new revenue opportunities while leveraging existing contracts for secure identity solutions. BIO-key's technology will be deployed in externally funded programs, with ongoing collaborations with the Technology Transfer Institute and local partners. Executives express optimism about growth in the African biometric market, asserting a strong position to capitalize on upcoming projects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.12%
Tags
none
-
Rhea-AI Summary

BIO-key International, Inc. (NASDAQ: BKYI) announced that Eastern Florida State College has selected its PortalGuard identity and access management (IAM) solution to enhance security and user experience. The previous IAM system was inadequate, prompting the college to choose BIO-key for its expertise in the educational sector. PortalGuard will facilitate seamless Single Sign-On (SSO) for approximately 30,000 students and staff, allowing for improved password management. The deployment process aims to be completed within two weeks after the procurement decision.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.92%
Tags
none
-
Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) has announced that its long-time client ICU Medical is expanding the use of BIO-key biometric authentication within its new staff training program. This enhancement aims to streamline check-ins and automate FDA compliance recordkeeping. Since 2005, ICU Medical has utilized BIO-key solutions to improve operations, effectively managing user access without physical tokens. The integration into the iLearning platform is expected to facilitate faster training sign-ins and improve user experience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.56%
Tags
none
Rhea-AI Summary

BIO-key International, Inc. (NASDAQ: BKYI) issued a statement addressing an inaccurate third-party press release regarding one of its partners, which has been removed. The company warns investors against relying on unverified information and commits to protecting its reputation and interests. BIO-key emphasizes its innovative identity and access management solutions powered by biometrics, which secure access to various platforms. The company is dedicated to safeguarding its economic opportunities following this incident.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.62%
Tags
none
-
Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) has appointed Kimberly Johnson as the new Vice-President of Product Marketing. Johnson will oversee product marketing strategies and execution, aiming to enhance the growth of the BIO-key PortalGuard IAM solution. With previous experience at GlobalSign, Imprivata, and BitSight, Johnson's expertise in IAM marketing is expected to significantly benefit the company. CEO Michael DePasquale highlighted her role in leading growth efforts for their biometrics products as they explore new markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.97%
Tags
none
-
Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) announced partnerships with three educational institutions to implement their PortalGuard identity and access management solution integrated with Campus.app. This collaboration aims to provide students with secure single-sign-on (SSO) capabilities, password management, and an enhanced digital campus experience, addressing challenges posed by remote learning during the pandemic. The solution is designed for ease of use and administration, enhancing security while improving user accessibility for educational software and resources.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

BIO-key International, Inc. (BKYI) reported Q2 2020 results, with revenues declining to $307,000 from $728,000 in Q2 2019, heavily impacted by COVID-19. The company completed a $2.5M acquisition of PistolStar and a $24.8M public offering, enhancing its financial position. Operating losses increased to $1.4M, while gross margin improved to 52% due to the elimination of certain expenses. Despite short-term challenges, BIO-key is optimistic about future opportunities in Africa, despite delays in contracts worth $75M.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of BIO-key International (BKYI)?

The current stock price of BIO-key International (BKYI) is $0.88 as of November 22, 2024.

What is the market cap of BIO-key International (BKYI)?

The market cap of BIO-key International (BKYI) is approximately 2.6M.

What does BIO-key International, Inc. do?

BIO-key is a provider of biometric software and hardware authentication solutions for enterprises and consumers, offering products like fingerprint readers and identity verification technologies.

When was BIO-key International, Inc. established?

BIO-key was established in 1993.

Who are BIO-key's customers?

BIO-key's customers include Fortune 500 companies, government agencies, healthcare organizations, call centers, schools, retailers, and OEM partners.

What are some popular products offered by BIO-key?

Some popular products include SideSwipe, SidePass, EcoID, WEB-key, and biometric padlocks like TouchLock.

What is the 'Biometric of Things' (BoT) initiative?

The BoT initiative aims to create biometrically enabled, consumer-friendly products that enhance security and user experience.

How does BIO-key generate revenue?

BIO-key generates revenue through services, license fees, and other streams.

What is the Humanity Protocol?

The Humanity Protocol is a blockchain-based economic empowerment initiative that uses BIO-key's biometric palm scan technology for identity verification, allowing individuals to claim their digital footprint through NFTs.

Who are BIO-key’s strategic partners?

One notable strategic partner is Humanity International Investments, led by His Highness, Sheikh Marwan bin Mohamed bin Rashid Al Maktoum.

Where can BIO-key products be purchased?

BIO-key products can be purchased through major retailers like Amazon, Microsoft, and Dell.com.

What type of biometric technology does BIO-key specialize in?

BIO-key specializes in fingerprint biometric technology for identification and identity verification.

BIO-key International, Inc.

Nasdaq:BKYI

BKYI Rankings

BKYI Stock Data

2.63M
2.93M
5.58%
9.26%
27.83%
Security & Protection Services
Services-prepackaged Software
Link
United States of America
HOLMDEL